|
Volumn 92, Issue 8, 2014, Pages e610-e614
|
Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration
a a a a |
Author keywords
age related macular degeneration; anti retinal autoantibodies; anti vascular endothelial growth factor therapy; bevacizumab
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
AUTOANTIBODY;
AUTOANTIGEN;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
VEGFA PROTEIN, HUMAN;
AGED;
ANTAGONISTS AND INHIBITORS;
BLOOD;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
FLUORESCENT ANTIBODY TECHNIQUE;
HUMAN;
IMMUNOLOGY;
INTRAVITREAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RETINA;
TREATMENT OUTCOME;
VERY ELDERLY;
VISUAL ACUITY;
WET MACULAR DEGENERATION;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
AUTOANTIBODIES;
AUTOANTIGENS;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
MIDDLE AGED;
RETINA;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
WET MACULAR DEGENERATION;
|
EID: 84923258209
PISSN: None
EISSN: 17553768
Source Type: Journal
DOI: 10.1111/aos.12435 Document Type: Article |
Times cited : (17)
|
References (0)
|